Form 8-K · Current report
PTC Inc. 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0000857005
- Accession no.
- 0001193125-26-323617
Summary
PTC Inc. reported third-quarter fiscal 2026 results, with constant-currency ARR excluding divested businesses up 9.1% and operating and free cash flow growth above the high ends of guidance; revenue was $600 million and GAAP EPS was $1.03. The company raised its fiscal 2026 guidance for ARR, revenue and EPS while reaffirming cash flow guidance, and repurchased about $525 million of shares in the quarter.
Key points
- PTC repurchased approximately $525 million of shares in Q3'26, bringing fiscal 2026 repurchases above the high end of its target for the year.
- PTC raised fiscal 2026 guidance for ARR, revenue and EPS while reaffirming cash flow guidance.
- Constant-currency ARR excluding divested businesses grew 9.1% year over year in Q3'26, exceeding the high end of its guidance range.
- Q3'26 revenue was $600 million, down 7% year over year, and non-GAAP EPS was $1.58, down 4%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 29, 2026, PTC Inc. announced results for its third quarter ended June 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1. Section 9 - Financial Statements and Exhibits Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 PTC Inc. Press Release dated July 29, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Exhibit 99.1: EX-99.1 2 ptc-ex99_1.htm EX-99.1 Ex 99.1 PTC Announces Third fiscal Quarter 2026 Results Strategic focus on Intelligent Product Lifecycle vision •Strong execution in Q3’26 across all key metrics oConstant currency ARR growth of 9.1%…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.